Johnson & Johnson reports first commercial Varipulse use in Canada
Johnson & Johnson MedTech (NYSE: JNJ) today announced the first completed commercial case with its Varipulse platform in Canada.
Johnson & Johnson MedTech (NYSE: JNJ) today announced the first completed commercial case with its Varipulse platform in Canada.
This overview highlights our upcoming conference coverage at the Fall Clinical Dermatology Conference in Las Vegas.
The age you’re most likely to end up in a doctor’s office is not when you’re young and dumb or old and wise. It’s when…
A new study from Cleveland Clinic reveals how SGLT-2 inhibitors may increase the risk of adverse urologic side effects.
Objectives The inclusion of rock-climbing in the Olympic Games has increased participation in the sport and attention to athletes’ health. In sports where the importance…
Podcast Episode · What’s Up with Tech? · 10/18/2024 · 22m
Background Patients with psychiatric disorders have increased all-cause mortality compared with the general population. Previous research has shown that there is a fourfold increased risk…
Inside a high-tech quest to demystify the deep sea—the most unexplored habitat on Earth
Between 1994 and 2004, the federal assault weapons ban prohibited the sale and manufacture of certain military-style semiautomatic weapons and high-capacity magazines in the US.…
Politics In Idaho and other states, draconian laws are forcing physicians to ignore their training and put patients’ lives at risk. September 12, 2024 Kylie…
The U.S. Food and Drug Administration on Tuesday approved Pfizer’s RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults…